topic

131 Coupled CAR® technology strengthens adoptive T cell therapy by promoting rapid expansion
Zhiyuan Cao, Chengfei Pu, Xianyang Jiang, Xiaogang Shen, Ruihong Zhu, Yuzhe Peng, Xi Huang, Zhao Wu, Lei Xiao

Journal for ImmunoTherapy of Cancer Nov 2020, 8 (Suppl 3) A80; DOI: 10.1136/jitc-2020-SITC2020.0131
138 In vivo localization of genetically engineered natural killer cells against glioblastoma using PET imaging
Yeonhee Yun, Jiao Wang, Karen Pollok, Tony Sinn, Randy Brutkiewicz, Sandro Matosevic, Michael Veronesi

Journal for ImmunoTherapy of Cancer Nov 2020, 8 (Suppl 3) A83-A84; DOI: 10.1136/jitc-2020-SITC2020.0138
780 Quantitative cell-based bioassays to advance immunotherapy programs targeting immune checkpoint receptors
Jamison Grailer, Julia Gilden, Pete Stecha, Denise Garvin, Jun Wang, Michael Beck, Jim Hartnett, Gopal Krishnan, Frank Fan, Mei Cong, Zhi-Jie Cheng

Journal for ImmunoTherapy of Cancer Nov 2020, 8 (Suppl 3) A830; DOI: 10.1136/jitc-2020-SITC2020.0780
141 PBMC-based cancer vaccines generated with microfluidics squeezing demonstrate synergistic and durable tumor reduction in combination with PD1 checkpoint and FAP targeted IL-2 variants
Matthew Booty, Adam Stockmann, Olivia Pryor, Melissa Myint, Christine Trumpfheller, Valeria Nicolini, Christian Klein, Laura Codarri, Pablo Umana, Armon Sharei, Howard Bernstein, Katherine Seidl, Scott Loughhead

Journal for ImmunoTherapy of Cancer Nov 2020, 8 (Suppl 3) A86; DOI: 10.1136/jitc-2020-SITC2020.0141
853 Profiling of donor-specific immune effector signatures in response to rituximab in a human whole blood loop assay using blood from CLL patients
Mohamed Eltahir, Erika Fletcher, Linn Dynesius, Justina Jarblad, Martin Lord, Ida Olsson, Mikaela Zekarias, Xiaojie Yu, Mark Cragg, Caroline Hammarstom, Kerstin Hamberg Levedahl, Martin Höglund, Gustav Ullenhag, Mattias Mattsson, Sara Mangsbo

Journal for ImmunoTherapy of Cancer Nov 2020, 8 (Suppl 3) A906; DOI: 10.1136/jitc-2020-SITC2020.0853
155 iPSC-derived NK cells mediate robust anti-tumor activity against glioblastoma
Jeffrey Miller, Frank Cichocki, Jianfang Ning, Ryan Bjordahl, Zachary Davis, Katie Tuininga, Hongbo Wang, Paul Rogers, Moyar Ge, Tom Lee, Bob Valamehr, Clark Chen

Journal for ImmunoTherapy of Cancer Nov 2020, 8 (Suppl 3) A93-A94; DOI: 10.1136/jitc-2020-SITC2020.0155
164 AgenT-797, a novel allogenic and ‘off-the shelf’ iNKT cell therapy promotes effective tumor killing
Burcu Yigit, Xavier Michelet, Shalu Kharkwal, Eleni Chantzoura, Jan Bergmann, Alvaro Sebastian Yague, Simon Yue, Darrian Moskowitz, Benjamin Wolf, Mark Exley, Dhan Chand, Marc Van Dijk

Journal for ImmunoTherapy of Cancer Nov 2020, 8 (Suppl 3) A98; DOI: 10.1136/jitc-2020-SITC2020.0164
474 Multiple combinational strategies of immunotherapy for esophageal squamous cell carcinoma: one institutional experience in Taiwan since 2016
Jo-Pai Chen, Wei-Chen Lu, Ruey-Long Hong

Journal for ImmunoTherapy of Cancer Nov 2020, 8 (Suppl 3) A290; DOI: 10.1136/jitc-2020-SITC2020.0474
244 Novel respirable antisense oligonucleotide (RASON) approach to primary and metastatic human lung cancer: preliminary results in a model system employing spontaneous lung tumors in dogs
Jonathan Nyce

Journal for ImmunoTherapy of Cancer Nov 2020, 8 (Suppl 3) A145-A146; DOI: 10.1136/jitc-2020-SITC2020.0244
746 Non small-cell lung cancer cells and cancer-associated fibroblasts drive macrophage polarization in a novel co-culture model
Josiah Flaming, Raghav Chandra, Luc Girard, Debolina Ganguly, Jason Toombs, John Minna, Rolf Brekken

Journal for ImmunoTherapy of Cancer Nov 2020, 8 (Suppl 3) A447-A448; DOI: 10.1136/jitc-2020-SITC2020.0746

Main menu

topic

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

topic

Pages